Showing results (11-20 of 67) with videos related to
Sort By:
Pageof 7
International Journal of Pharmaceutics|March 24, 2020
Hypoxia-responsive folic acid conjugated glycol chitosan nanoparticle for enhanced tumor targeting treatmentEun Hyang Jang, Man Kyu Shim, Gye Lim Kim, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|May 25, 2023
Immune checkpoint-targeted drug conjugates: A promising tool for remodeling tumor immune microenvironmentJiwoong Choi, Hochung Jang, Jiwon Choi, et al.Journal of Materials Chemistry. B|April 28, 2021
Rediscovery of nanoparticle-based therapeutics: boosting immunogenic cell death for potential application in cancer immunotherapySuah Yang, In-Cheol Sun, Hee Sook Hwang, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|November 5, 2020
Combination of cancer-specific prodrug nanoparticle with Bcl-2 inhibitor to overcome acquired drug resistanceJinseong Kim, Man Kyu Shim, Suah Yang, et al.Journal of Nanobiotechnology|March 9, 2023
In vivo toxicity evaluation of tumor targeted glycol chitosan nanoparticles in healthy mice: repeated high-dose of glycol chitosan nanoparticles potentially induce cardiotoxicityHyeyoun Chang, Ji Young Yhee, Sangmin Jeon, et al.Plastic and Reconstructive Surgery|June 15, 2026
Therapeutic Potential of Bovine Colostrum-Derived Exosomes for Ischemia-Reperfusion Injury in Skin Flaps: A Rat Model StudyYoung Chul Kim, Yeongji Jang, Youngsam Kim, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|January 28, 2021
Targeting of claudin-4 by Clostridium perfringens enterotoxin-conjugated polysialic acid nanoparticles for pancreatic cancer therapyMan Kyu Shim, Jinhee Na, In Kyung Cho, et al.International Journal of Pharmaceutics|February 10, 2017
Hydrophobically modified polysaccharide-based on polysialic acid nanoparticles as carriers for anticancer drugsBom Jung, Man-Kyu Shim, Min-Ju Park, et al.Pharmaceutics|January 21, 2022
Cathepsin B-Overexpressed Tumor Cell Activatable Albumin-Binding Doxorubicin Prodrug for Cancer-Targeted TherapyHanhee Cho, Man Kyu Shim, Suah Yang, et al.Bioconjugate Chemistry|January 5, 2021
Intracellular Uptake Mechanism of Bioorthogonally Conjugated Nanoparticles on Metabolically Engineered Mesenchymal Stem CellsSeungho Lim, Woojun Kim, Sukyung Song, et al.Pageof 7